The Role of Hyperuricemia in the Increased Cytokine Production After Lipopolysaccharide Challenge in Neutropenic Mice
Authors:
Open Access
- 15 January 1997
- journal article
- Published by American Society of Hematology in Blood
- Vol. 89 (2) , 577-582
Abstract
Patients with severe granulocytopenia are more susceptible to severe infections and sepsis. Proinflammatory cytokines such as tumor necrosis factor-α (TNF ), interleukin-1α (IL-1α), and IL-1β play an important role in the pathophysiology of sepsis. The profile of these proinflammatory cytokines after lipopolysccharide (LPS) challenge in cyclophosphamide-induced neutropenic mice was assessed, and possible mechanisms responsible for the modified cytokine production were studied. After LPS, both circulating concentrations of TNF and IL-1α in neutropenic mice were 50% to 200% higher than those of controls, whereas IL-1β concentrations were not modified. The kinetics of cytokine production were similar in neutropenic and control animals. The susceptibility of neutropenic mice to an LPS challenge was increased. The observed overproduction of TNF and IL-1α was not due to a direct effect of cyclophosphamide treatment. Because circulating concentrations of uric acid were increased in the neutropenic mice, the effect of hypouricemic treatment with allopurinol and sodium bicarbonate was investigated; such treatment in neutropenic mice challenged with LPS was followed by an improved survival and a reduced proinflammatory cytokine production towards the concentrations in control mice. Hyperuricemia induced by repeated administrations of uric acid in normal mice led to an increased TNF production after LPS. In conclusion, neutropenic mice respond with enhanced cytokine production and increased susceptibility to an LPS challenge, and hyperuricemia probably plays an important role in this phenomenon.Keywords
This publication has 22 references indexed in Scilit:
- Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections.Journal of Clinical Investigation, 1996
- Pharmacologic Inhibitors of Tumor Necrosis Factor Production Exert Differential Effects in Lethal Endotoxemia and in Infection with Live Microorganisms in MiceThe Journal of Infectious Diseases, 1995
- Granulocytopenia Reduces Release of Soluble TNF Receptor p75 in Endotoxin-Stimulated Mice: A Possible Mechanism of Enhanced TNF ActivityCytokine, 1995
- Increase In Interleukin-6 Serum Level Preceding Fever In Granulocytopenia And Correlation With Death From SepsisThe Journal of Infectious Diseases, 1995
- Cyclophosphamide uncovers two separate macrophage subpopulations with opposite immunogenic potential and different patterns of monokine productionCytokine, 1994
- Cytokine and Acute-Phase Reactant Levels in Serum of Children with Cancer Admitted for Fever and NeutropeniaThe Journal of Infectious Diseases, 1992
- A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice.Journal of Experimental Medicine, 1991
- Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution.Journal of Clinical Investigation, 1991
- Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin FeverThe Journal of Infectious Diseases, 1990
- Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemiaNature, 1987